Literature DB >> 3321443

Current chemotherapeutic treatment approaches to the management of previously untreated adults with de novo acute myelogenous leukemia.

R J Mayer1.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3321443

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  7 in total

1.  Induction chemotherapy for newly diagnosed acute myeloid leukaemia using a regime containing cytosine arabinoside, daunorubicin and etoposide.

Authors:  R Liang; E Chiu; T K Chan; D Todd
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Acute leukemias in adults: an overview of recent strategies.

Authors:  R J Mayer
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

3.  Combination of pipemidic acid, colistin sodium methanesulfonate and nystatin may be less effective than nystatin alone for prevention of infection during chemotherapy-induced granulocytopenia in acute leukemia.

Authors:  K Sampi; M Sakurai; R Kumai; N Maseki; Y Kaneko; M Hattori
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

4.  Effect of 6-thioguanine on Chlamydia trachomatis growth in wild-type and hypoxanthine-guanine phosphoribosyltransferase-deficient cells.

Authors:  B Qin; G McClarty
Journal:  J Bacteriol       Date:  1992-05       Impact factor: 3.490

5.  High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia. Long-term follow-up of a prospective multicenter trial.

Authors:  G Heil; P S Mitrou; D Hoelzer; M Freund; H Link; G Ehninger; B Steinke; S Ohl; H Wandt; E Fackler-Schwalbe
Journal:  Ann Hematol       Date:  1995-11       Impact factor: 3.673

6.  High-dose cytosine arabinoside plus etoposide as initial treatment for acute myeloid leukaemia: a single centre study.

Authors:  P Parikh; R Powles; J Treleaven; G Helenglass; M Gore; M Rose; D Talbot; S Milan; C Smith; R Pinkerton
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

7.  Selective Intratumoral Drug Release and Simultaneous Inhibition of Oxidative Stress by a Highly Reductive Nanosystem and Its Application as an Anti-tumor Agent.

Authors:  Chunqi Zhu; Lihua Luo; Xindong Jiang; Mengshi Jiang; Zhenyu Luo; Xiang Li; Weigen Qiu; Zhaolei Jin; Tianxiang Shen; Chunlong Li; Qingpo Li; Yunqing Qiu; Jian You
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.